Researchers discover new type of technology to detect ovarian cancer - Video
Overview
A new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study by a Wilmot Cancer Institute physician/scientist.
Nearly 200 local people participated in the study, which was led by Richard Moore, M.D., director of the Wilmot Cancer Institute's Gynecologic Oncology program at the University of Rochester Medical Center. Results were published on Sept. 8, 2022, in the high-impact Obstetrics & Gynecology "Green" journal.
Reference:
Moore, Richard George MD et al, Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass, Obstetrics and Gynecology, Sep 2022 DOI: 10.1097/AOG.0000000000004927
Speakers
